AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 OCT 24 - (NewsRx.com & NewsRx.net) -- AlleCure Corp. will collaborate with BD Biosciences (BDB), a division of BD (Becton, Dickinson and Co.), to develop novel assays in support of AlleCure's AlleVax treatments for allergies and various autoimmune diseases. Leveraging BD Biosciences research and clinical diagnostic systems and AlleCure's allergy vaccine technologies, the collaboration will focus on the development of laboratory tests that may be used for allergy diagnosis, confirmation of vaccine efficacy, and continued patient monitoring before, during, and after immunotherapy.
AlleCure and BD Biosciences will collaborate to complement AlleCure's current allergy vaccine development program. BD Biosciences' integrated approach is designed to accelerate drug discovery and diagnosis through the development and implementation of assays for research and clinical use. These laboratory tests will be designed to improve the identification of patients with specific allergies, as well as to monitor how well the vaccines are working.
"In the general field of vaccine-based therapeutics, it is essential to have available convenient laboratory assays for the assessment of the relevant ...
Source: HighBeam Research, AlleCure Announces Alliance With BD Biosciences.